Risk assessment and risk-based therapy in febrile neutropenic patients

被引:0
作者
K. V. I. Rolston
机构
[1] University of Texas M. D. Anderson Cancer Center,Section of Infectious Diseases, Department of Medical Specialties
来源
European Journal of Clinical Microbiology and Infectious Diseases | 1998年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:461 / 463
页数:2
相关论文
共 68 条
  • [1] Bodey GP(1966)Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Annals of Internal Medicine 64 328-340
  • [2] Buckley M(1990)Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever Journal of Infectious Diseases 161 381-396
  • [3] Sathe YS(1988)The medical course of cancer patients with fever and neutropenia. Clinical identification on a low-risk subgroup at presentation Archives of Internal Medicine 148 2561-2568
  • [4] Freireich EJ(1992)Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule Journal of Clinical Oncology 10 316-322
  • [5] Hughes WT(1997)1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever Clinical Infectious Diseases 25 551-573
  • [6] Armstrong D(1993)Management of fever in patients with cancer and treatment induced neutropenia New England Journal of Medicine 328 1323-1332
  • [7] Bodey GP(1988)Controversies in the management of febrile neutropenic cancer patients Cancer Investigation 6 167-184
  • [8] Feld R(1984)Antibiotics in patients with neutropenia Archives of Internal Medicine 144 1845-1851
  • [9] Mandell GL(1992)A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients Archives of Internal Medicine 152 283-291
  • [10] Meyers JD(1993)Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer Cancer 71 3640-3646